VANCOUVER, BC--(Marketwire - January 16, 2008) - TapImmune Inc. (OTCBB: TPIM), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced it has retained ROI Group LLC as investor relations counsel.
